Skip to main content

Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder

Buy Article:

$51.00 plus tax (Refund Policy)

Shelton RC, Papakostas GI. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Objective: 

Atypical antipsychotics (AAPs) have been hypothesized to be beneficial in treatment-resistant depression (TRD). This paper will review a biochemical rationale and will summarize the data regarding the effectiveness of AAPs in TRD. Method: 

Studies were identified using searches of Pubmed/Medline, EMBase and the Cochrane databases by cross-referencing the term ‘depression’ with each of the six AAPs. Results: 

After initial positive, short case reports and clinical trials, larger studies failed to show the effectiveness of AAPs combined with antidepressants for TRD. More recently, larger scale clinical trials have supported the effectiveness of at least some of these medications. While AAPs have gained in popularity for TRD, there are nagging concerns regarding risks such as metabolic syndrome and tardive dyskinesia. Conclusion: 

The existing research provides some support for the beneficial effects of AAPs when combined with SSRI’s in TRD. These medications pose significant risks that must be considered in their use.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: antidepressants; atypical antipsychotics; augmentation; major depressive disorder; treatment resistant

Document Type: Research Article

Affiliations: 1: Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA 2: Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Publication date: 2008-04-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more